Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Repurposed Use of the Alkaloids Emetine and Cephaeline to Treat Zika Virus Infection
Case ID:
TAB-3595
Web Published:
12/6/2022
This technology includes the use of two related compounds, Emetine and Cephaeline, as a potent inhibitor of the Zika virus (ZIKV). Emetine and it's analog Cephaeline were identified in a high-throughput assay aimed at identifying anti-ZIKV compounds. Both Emetine and Cephaeline are potent inhibitors of ZIKV infection in cell culture, and Emeline is a potent inhibitor of ZIKV infection in a live mouse model. These compounds were previously identified in an ipecac root crude extract which was used as a treatment for amoebic dysentery in addition to being used as an emetic agent, depending on dosage. While there has been some cardiotoxicity reported with high dosage of emetine, the effective IC50 observed in cell culture and mice is well below the toxic dosage.
Patent Information:
Title
App Type
Country
Serial No.
Patent No.
File Date
Issued Date
Expire Date
Direct Link:
https://canberra-ip.technologypublisher.com/tech/Repurposed_Use_of_the_Alkalo ids_Emetine_and_Cephaeline_to_Treat_Zika_Virus_Infection
Keywords:
compounds
Emetine
Flavivirus
Infection
Prevention
treatment
VLXXXX
WIXXXX
WKXXXX
Bookmark this page
Download as PDF
For Information, Contact:
Suryanarayana Vepa
Deputy Director; OSA
NIH Technology Transfer
301-827-7181
sury.vepa@nih.gov